Determination of the annual coefficient for the revaluation of taxes
As part of its tasks relating to the assessment and risk management of veterinary medicinal products, ANSES collects taxes and fees. Taxes, with the exception of the annual tax indexed to the turnover of veterinary medicinal products, are revalued annually.
The revaluation coefficient is determined, in accordance with the provisions of Article L. 5141-8 of the Public Health Code, in accordance with the projected annual average trend in consumer prices excluding tobacco for the year in question in the economic, social and financial report annexed to the draft finance law. Its amount shall be rounded up to the higher euro.
The economic, social and financial report for 2024 foresees an annual change of 2.5 % for 2024 (change in the consumer price index excluding tobacco products). This revaluation will apply from 1 January 2024 to fees relating to files of:
- Application for marketing authorisation for a veterinary medicinal product;
- Application for an amendment of a marketing authorisation requiring an evaluation;
- Application for parallel trade authorisation;
- Request for prior authorisation for advertising;
- Declaration of advertising;
- Issue of export certificates by the Director-General of the French Agency for Food, Environmental and Occupational Health and Safety;
- Application for registration of veterinary medicinal products
as well as the annual fees relating to:
- Authorisations for veterinary pharmaceutical establishments;
- Declarations of facilities carrying out the non-clinical trials referred to in Article L. 5141-4.
For royalties, an increase of 4.9 % (inflation excluding tobacco products in the Finance Bill 2024) will apply on 1 January 2024. These relate to the following services:
- Inspections
- Official batch release – OCABR and OBPR procedures
- Certified copy of decision